Display options
Cite
Zolfaghari PS, Pinto BB, Dyson A, et al. The metabolic phenotype of rodent sepsis: cause for concern?. Intensive Care Med Exp. 2013;1(1):25doi: 10.1186/2197-425X-1-6.
Zolfaghari, P. S., Pinto, B. B., Dyson, A., & Singer, M. (2013). The metabolic phenotype of rodent sepsis: cause for concern?. Intensive care medicine experimental, 1(1), 25. https://doi.org/10.1186/2197-425X-1-6
Zolfaghari, Parjam S, et al. "The metabolic phenotype of rodent sepsis: cause for concern?." Intensive care medicine experimental vol. 1,1 (2013): 25. doi: https://doi.org/10.1186/2197-425X-1-6
Zolfaghari PS, Pinto BB, Dyson A, Singer M. The metabolic phenotype of rodent sepsis: cause for concern?. Intensive Care Med Exp. 2013 Dec;1(1):25. doi: 10.1186/2197-425X-1-6. Epub 2013 Oct 29. PMID: 26266794; PMCID: PMC4797805.
Copy Download .nbib Format: NLM
Share it on

Intensive Care Med Exp. 2013 Dec;1(1):25. doi: 10.1186/2197-425X-1-6. Epub 2013 Oct 29.

The metabolic phenotype of rodent sepsis: cause for concern?.

Intensive care medicine experimental

Parjam S Zolfaghari, Bernardo Bollen Pinto, Alex Dyson, Mervyn Singer

Affiliations

  1. Bloomsbury Institute of Intensive Care Medicine, University College London, Cruciform Building, Gower St, London, WC1E 6BT, UK, [email protected].

PMID: 26266794 PMCID: PMC4797805 DOI: 10.1186/2197-425X-1-6

Abstract

PURPOSE: Rodent models of sepsis are frequently used to investigate pathophysiological mechanisms and to evaluate putative therapeutic strategies. However, preclinical efficacy in these models has failed to translate to the clinical setting. We thus questioned the representativeness of such models and herein report a detailed comparison of the metabolic and cardiovascular phenotypes of long-term faecal peritonitis in fluid-resuscitated rats and mice with similar mortality profiles.

METHODS: We conducted prospective laboratory-controlled studies in adult male Wistar rats and C57 black mice. Animals were made septic by intraperitoneal injection of faecal slurry. Rats received continuous intravenous fluid resuscitation, whereas mice received intermittent fluid boluses subcutaneously. Sham-treated animals served as controls. Survival was assessed over 72 h. In separate studies, whole body metabolism (O2 consumption, CO2 production) was measured over 24 h with echocardiography performed at early (6 h) and established (24 h) phases of sepsis. Blood gas analysis was performed at 6 h (rats) and 24 h (rats, mice).

RESULTS: Similar survival curves were seen in both rodent models with approximately 75% mortality at 72 h. In mice, sepsis caused severity-dependent falls in core temperature and global metabolism. Oxygen consumption in severely septic mice fell by 38% within 2 h, and 80% at 22 h compared with baseline values. This was only partially restored by external warming. By contrast, septic rats maintained core temperature; only severely affected animals showed a pre-mortem decline in oxygen consumption. Significant myocardial dysfunction was seen in mice during early and established sepsis, whereas peak velocity and other hemodynamic variables in rats were similar at 6 h and significantly worse by 24 h in severely septic animals only.

CONCLUSIONS: Markedly differing metabolic and cardiovascular profiles were seen in long-term fluid-resuscitated rat and mouse models of bacterial sepsis despite similar mortality. The mouse model, in particular, does not represent the human condition. We urge caution in applying findings in murine models to septic patients, both with regard to our understanding of pathophysiology and the failure to translate preclinical efficacy into successful clinical trials.

References

  1. Intensive Care Med. 2011 Jul;37(7):1192-200 - PubMed
  2. Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E512-20 - PubMed
  3. Acad Emerg Med. 2005 Apr;12(4):275-81 - PubMed
  4. Am J Physiol Regul Integr Comp Physiol. 2004 Mar;286(3):R491-7 - PubMed
  5. Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1244-52 - PubMed
  6. Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H691-7 - PubMed
  7. Front Biosci. 2004 May 01;9:1877-88 - PubMed
  8. N Engl J Med. 2012 Nov 15;367(20):1901-11 - PubMed
  9. Biochem Soc Trans. 2001 Nov;29(Pt 6):751-5 - PubMed
  10. Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12 - PubMed
  11. Crit Care Med. 2009 Jan;37(1 Suppl):S30-7 - PubMed
  12. Lancet. 2004 Aug 7-13;364(9433):545-8 - PubMed
  13. Crit Care Med. 2011 Oct;39(10 ):2290-3 - PubMed
  14. Lancet. 2002 Jul 20;360(9328):219-23 - PubMed
  15. Life Sci. 2000 Sep 29;67(19):2319-29 - PubMed
  16. Crit Care Med. 1991 Sep;19(9):1138-45 - PubMed
  17. Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H526-33 - PubMed
  18. Shock. 1995 Oct;4(4):269-73 - PubMed
  19. Comp Biochem Physiol A Mol Integr Physiol. 2009 Jun;153(2):95-105 - PubMed
  20. Crit Care Med. 2005 Dec;33(12):2752-6 - PubMed
  21. J Surg Res. 2011 Sep;170(1):e123-34 - PubMed
  22. Shock. 2003 Jun;19(6):570-6 - PubMed
  23. FASEB J. 2007 Nov;21(13):3431-41 - PubMed
  24. Nat Rev Drug Discov. 2005 Oct;4(10):854-65 - PubMed
  25. Crit Care Med. 1993 Jul;21(7):1012-9 - PubMed
  26. Crit Care Med. 2001 Jul;29(7):1303-10 - PubMed
  27. Crit Care Med. 1999 Jul;27(7):1295-302 - PubMed
  28. Infect Immun. 1996 Mar;64(3):769-74 - PubMed
  29. J Exp Biol. 2002 Aug;205(Pt 15):2287-96 - PubMed
  30. Annu Rev Nutr. 1987;7:187-208 - PubMed
  31. JAMA. 1993 Oct 13;270(14):1724-30 - PubMed
  32. Clin Sci (Lond). 2013 Mar;124(6):391-401 - PubMed
  33. Cytokine. 2001 May 7;14(3):162-9 - PubMed
  34. Circulation. 1990 Jan;81(1 Suppl):II14-30 - PubMed
  35. Acta Anaesthesiol Scand. 2004 Jan;48(1):74-81 - PubMed
  36. Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E433-46 - PubMed
  37. Am J Physiol Regul Integr Comp Physiol. 2007 Nov;293(5):R1833-45 - PubMed
  38. Biochem J. 2001 Apr 15;355(Pt 2):389-95 - PubMed
  39. Physiol Biochem Zool. 2001 May-Jun;74(3):390-7 - PubMed
  40. N Engl J Med. 2012 Jul 12;367(2):124-34 - PubMed
  41. Genetics. 2003 Apr;163(4):1227-35 - PubMed

Publication Types